Home » Topics » BioWorld Science

BioWorld Science
RSS

Compugen announces IND clearances for BAY-1905254 and COM-701

July 3, 2018

FDA grants fast track designation to CUTX-101 for treatment of classic Menkes disease

July 3, 2018

FDA awards regenerative medicine advanced therapy designation to romyelocel-L

July 3, 2018

Ocugen initiates first pivotal trial of OCU-300 for ocular graft-versus-host disease

July 3, 2018

Cereno reports results from first clinical study of CS-1

July 3, 2018

Bacteriophages adjuvant therapy tested in patients with severe staphylococcal sepsis

July 3, 2018

Gazyva receives approval in Japan

July 3, 2018

Nipro applies for approval of human stem cell therapy product for spinal cord injury

July 3, 2018

Cell therapies wake up and smell the coffee

July 3, 2018

Separating the good, the bad and the indifferent in neurodegeneration

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...